ERS GENOMICS

ers-genomics-logo

ERS Genomics is a biotechnology company to provide broad access to the foundational CRISPR-Cas9 intellectual property. The CRISPR-Cas9 utilizes a molecular complex comprised of the protein Cas9 together with one or more guide RNAs which binds to the genome in living cells at any desired locations and also offers significant advantages in cost, speed, efficiency over the earlier genome editing methods. ERS Genomics was founded in 2014 and is headquartered in Dublin, Ireland.

#People #Website #More

ERS GENOMICS

Social Links:

Industry:
Biotechnology Intellectual Property

Founded:
2014-01-01

Address:
Dublin, Dublin, Ireland

Country:
Ireland

Website Url:
http://www.ersgenomics.com

Total Employee:
1+

Status:
Active

Contact:
+353 1 539-0082

Email Addresses:
info@ersgenomics.com

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network


Current Employees Featured

eric-rhodes_image

Eric Rhodes
Eric Rhodes CEO @ ERS Genomics
CEO
2016-06-01

shaun-foy_image

Shaun Foy
Shaun Foy Chairman of the Board and Co-Founder @ ERS Genomics
Chairman of the Board and Co-Founder
2014-02-01

emmanuelle-charpentier_image

Emmanuelle Charpentier
Emmanuelle Charpentier Scientific Advisor and Co-Founder @ ERS Genomics
Scientific Advisor and Co-Founder

Founder


emmanuelle-charpentier_image

Emmanuelle Charpentier

shaun-foy_image

Shaun Foy

Official Site Inspections

http://www.ersgenomics.com

  • Host name: 63.220.178.68.host.secureserver.net
  • IP address: 68.178.220.63
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "ERS Genomics"

Express License - ERS Genomics

Verified Organization Email. Company LinkedIn Page, linked to employee’s personal LinkedIn. Published CRISPR research paper associated with company or employee. Evidence of …See details»

ERS Genomics and IRBM sign CRISPR/Cas9 license …

May 20, 2024 For additional information please visit www.ersgenomics.com. About IRBM www.irbm.com. IRBM is a scientific contract research organization (CRO) that stands at the forefront of drug discovery, leveraging a single, …See details»

ERS Genomics - Crunchbase Company Profile & Funding

ERS Genomics is a biotechnology company to provide broad access to the foundational CRISPR-Cas9 intellectual property. The CRISPR-Cas9 utilizes a molecular complex comprised of the …See details»

ERS Genomics - LinkedIn

If you are attending the conference and would like to meet, get in touch here: info@ersgenomics.com. 14 1 Comment Like Comment Share ERS Genomics 1,485 followers ...See details»

ERS Genomics - Technology Networks

ERS Genomics was formed to commercialize the foundational CRISPR-Cas9 intellectual property held by co-inventor, co-owner and Nobel Prize-winner Dr. Emmanuelle Charpentier. The team …See details»

ERS Genomics - VentureRadar

Website: http://www.ersgenomics.com/ ERS Genomics was formed to provide broad access to the foundational CRISPR-Cas9intellectual property held by Dr. Emmanuelle ...See details»

The Global Leader in CRISPR/Cas9 Licensing - ERS Genomics

Info@ersgenomics.com ERS Genomics Ltd 8th Floor, Block E, Iveagh Court, Harcourt Road, Dublin D02 YT22, Ireland. Title: ERS_3.2.21 Created Date: 1/31/2023 1:22:54 PM ...See details»

ERS Genomics - Overview, News & Similar companies - ZoomInfo

Who is ERS Genomics. ERS Genomics is a biotechnology company based in Dublin, Ireland. The company was formed to provide broad access to the foundational CRISPR/Cas9 in tellectual …See details»

About ERS and Our CRISPR/Cas9 Credentials | ERS …

Founded in 2014, ERS Genomics is the world's leading provider of access to the proprietary rights to foundational CRISPR/Cas9 patents.See details»

Crown Bioscience and ERS Genomics Announce Global …

Dec 8, 2022 Crown Bioscience is a global contract research organization (CRO) supporting drug discovery and development for oncology, immuno-oncology, and immune-mediated …See details»

ERS Genomics and GenScript Biotech Corporation Sign …

May 12, 2021 About GenScript Biotech Corporation GenScript Biotech Corporation (Stock Code: 1548.HK) is a global biotechnology group. Based on its leading gene synthesis technology, …See details»

ERS Genomics Limited ('ERS') completes licensing agreement with …

Oct 18, 2023 ERS Genomics, co-founded by Dr. Emmanuelle Charpentier, a recipient of the 2020 Nobel Prize in Chemistry for her pioneering work on CRISPR/Cas9, provides access to …See details»

Ricoh and ERS Genomics enter into CRISPR/Cas9 license agreement

Mar 13, 2024 ERS Genomics was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property held by Dr. Emmanuelle Charpentier. Non-exclusive …See details»

ERS Genomics Limited ('ERS') completes licensing agreement with …

Oct 19, 2023 ERS Genomics Limited ('ERS') completes licensing agreement with Syngene International, India's leading Contract Research, Development and Manufacturing …See details»

ERS Genomics launches ‘Express License’ platform to democratise …

Jan 13, 2025 To support small and early-stage organizations, ERS now offers a non-exclusive Express License for internal research use, specifically designed for companies with fewer than …See details»

New CRISPR/Cas9 license agreement for ERS Genomics and …

Jun 28, 2022 ERS Genomics Limited (‘ERS’) is pleased to announce a new license agreement with Cytosurge AG (‘Cytosurge‘). This is a non-exclusive licensing agreement granting …See details»

ERS Genomics and GenScript Biotech Corporation sign

May 12, 2021 Dublin, Ireland and Piscataway, New Jersey, 12 May 2021 - ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 …See details»

ERS Genomics Limited ('ERS') completes licensing agreement with …

Dublin, Ireland – 19/10/2023** - ERS Genomics Limited ('ERS') completes licensing agreement with Syngene International, India's leading Contract Research, Syngene gains access to ERS …See details»

NHGRI appoints Erin Ramos as the next director of the Division of ...

Dec 29, 2024 The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), has appointed Erin Ramos, Ph.D., M.P.H., as the director of the …See details»

CRISPR/Cas9 Genomics, Research & Insights | ERS Genomics

Jan 28, 2025 Get the very latest gene engineering industry news from the principle authority on CRISPR/Cas9 technology, innovation and licensing worldwide.See details»